Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Nivolumab and Ipilimumab for the Treatment of Patients with Locally Advanced, Metastatic, or Unresectable Liver Cancer

Liver

This phase II trial tests whether nivolumab and ipilimumab works to shrink tumors in patients with liver cancer that has spread to nearby tissue or lymph nodes (locally advanced), has spread to other places in the body (metastatic), or cannot be removed by surgery (unresectable). Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Nivolumab and ipilimumab may be effective in killing tumor cells in patients with liver cancer.
Liver
II
Goff, Laura
NCT05199285
VICCGI2277

Clinical Trials Search CTA Inline Referral Form

To learn more about any of our clinical
trials, call 615-936-8422.